Envoy Medical, Inc. Class A COCH 深 沪
等待开盘 02-07 09:30:00 美东时间
0.4911
-0.039
-7.34%
华盛通- 最 高0.5513
- 今 开0.5237
- 成交量 20.84万股
- 最 低 0.4911
- 昨 收 0.53
- 总市值 1413.71万
- 52周最高 1.91
- 市盈率 静 --
- 换手率 0.72%
- 52周最低 0.4911
- 委 比 -33.33%
- 总股本 2878.65万
- 历史最高 11.72
- 量 比 2.03
- 振 幅 11.36%
- 历史最低 0.00
- 每 手 1
- 风险率 0.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Envoy Medical Announces Its Pivotal Clinical Trial For Acclaim Cochlear Implant Reaches Midway Point Of Study's Full Enrollment Program
Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that its pivotal clinical study for the investigational
2025-12-18 21:12
Envoy Medical Announces Completion Of First Set Of Activations In Final Stage Of Pivotal Clinical Study For Investigational Fully Implanted Acclaim Cochlear Implant
Momentum continues to build for Company as series of clinical milestones are met, design choices cement differentiation from competition, and timeline comes into focusWhite Bear Lake, Minnesota--(Newsfile Corp. -
2025-12-10 21:11
Envoy Medical Announces USPTO Patent Issuance Advancing Fully Implanted Hearing Technology
Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of U.S. Patent No. 12,465,754, granted by the
2025-11-20 21:10
Envoy Medical Q3 EPS $(0.35) Misses $(0.28) Estimate, Sales $42.000K Miss $70.000K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.28) by 25 percent. This is a 10.26 percent increase over losses of $(0.39) per share from the
2025-11-10 21:15
Envoy Medical Enrolls First Three Participants In Final Stage In Pivotal Clinical Study Of Full Implanted Acclaim Cochlear Implant
Envoy Medical, Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that the first three patients have been enrolled in the final
2025-11-04 21:11
Envoy Medical Granted Nasdaq Extension Until February 23, 2026 To Regain Full Compliance
Envoy Medical, Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that the Nasdaq Hearings Panel (the "Panel) has granted the
2025-10-27 20:12
Envoy Medical Raises $4 Million in Stock Offering
Envoy Medical ( ($COCH) ) has issued an update. On October 7, 2025, Envoy Medic...
2025-10-09 21:48
Dow Jumps Over 100 Points; US Crude Oil Inventories Increase
U.S. stocks traded higher midway through trading, with the Dow Jones index gain...
2025-10-09 01:22
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock moved upwards by 137.1% to $10...
2025-10-09 01:06
Nasdaq Gains 150 Points; US Mortgage Applications Decline
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more ...
2025-10-08 22:22
